Stefanie Blejec, Rose Cytryn, Radhi Yagnik, Nina A Bickell, Jenny J Lin
{"title":"Facilitators of Multiple Myeloma Treatment: A Qualitative Study.","authors":"Stefanie Blejec, Rose Cytryn, Radhi Yagnik, Nina A Bickell, Jenny J Lin","doi":"10.1188/23.ONF.372-380","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To examine factors that lead to the facilitation of multiple myeloma (MM) treatment.</p><p><strong>Sample & setting: </strong>29 patients who had been diagnosed with MM at Mount Sinai Hospital in New York City.</p><p><strong>Methods & variables: </strong>Semistructured qualitative interviews were administered by trained research staff. Interview topics included illness beliefs, illness experiences, treatment experiences, and treatment decision-making. Interviews were audio recorded and transcribed verbatim. Four coders independently coded the transcripts, and the authors analyzed data using interpretive description.</p><p><strong>Results: </strong>The following facilitators of treatment were identified: (a) healthcare team trust and support, (b) personal resilience and initiative-taking, and (c) external support (emotional/social support and instrumental/organizational support). Healthcare team trust and support were established through rapport-building and compassion, accessibility and time spent with the patient, shared decision-making, and provider reputation. Personal resilience was manifested by patients through positive attitudes, taking control of their illness, and self-advocacy.</p><p><strong>Implications for nursing: </strong>Understanding factors that facilitate MM treatment may lead to better patient outcomes and can potentially inform oncology nursing practice by providing a framework for tailored health education and care management practices for patients with MM.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"50 3","pages":"372-380"},"PeriodicalIF":1.6000,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology nursing forum","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1188/23.ONF.372-380","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To examine factors that lead to the facilitation of multiple myeloma (MM) treatment.
Sample & setting: 29 patients who had been diagnosed with MM at Mount Sinai Hospital in New York City.
Methods & variables: Semistructured qualitative interviews were administered by trained research staff. Interview topics included illness beliefs, illness experiences, treatment experiences, and treatment decision-making. Interviews were audio recorded and transcribed verbatim. Four coders independently coded the transcripts, and the authors analyzed data using interpretive description.
Results: The following facilitators of treatment were identified: (a) healthcare team trust and support, (b) personal resilience and initiative-taking, and (c) external support (emotional/social support and instrumental/organizational support). Healthcare team trust and support were established through rapport-building and compassion, accessibility and time spent with the patient, shared decision-making, and provider reputation. Personal resilience was manifested by patients through positive attitudes, taking control of their illness, and self-advocacy.
Implications for nursing: Understanding factors that facilitate MM treatment may lead to better patient outcomes and can potentially inform oncology nursing practice by providing a framework for tailored health education and care management practices for patients with MM.
期刊介绍:
The mission of the Oncology Nursing Forum, an official publication of ONS, is to
Convey research information related to practice, technology, education, and leadership.
Disseminate oncology nursing research and evidence-based practice to enhance transdisciplinary quality cancer care.
Stimulate discussion of critical issues relevant to oncology nursing.